These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7427172)

  • 1. Diuretic resistance: reduced bioavailability and effect of oral frusemide.
    Odlind BO; Beermann B
    Br Med J; 1980 Jun; 280(6231):1577. PubMed ID: 7427172
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability of two preparations of frusemide.
    Paton DM
    N Z Med J; 1980 Mar; 91(656):208-10. PubMed ID: 6929997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannitol and frusemide in the treatment of diuretic resistant oedema in nephrotic syndrome.
    Lewis MA; Awan A
    Arch Dis Child; 1999 Feb; 80(2):184-5. PubMed ID: 10325739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretic resistance?
    Lancet; 1979 Feb; 1(8110):253-4. PubMed ID: 84907
    [No Abstract]   [Full Text] [Related]  

  • 5. [Synergistic effect of furosemide and metolazone in edema cases difficult to handle].
    Jacobson S; Berglund J; Lins LE
    Lakartidningen; 1987 Mar; 84(11):846. PubMed ID: 3561104
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of frusemide on 'resistant' oedema.
    Kok LS; Teik KO
    Singapore Med J; 1967 Dec; 7(4):250-2. PubMed ID: 6036646
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of furosemide, a new oral diuretic, in the nephrotic syndrome.
    Gros G; Greene JA; Weller JM
    Mich Med; 1966 Nov; 65(11):949-52. PubMed ID: 5979471
    [No Abstract]   [Full Text] [Related]  

  • 8. Discrimination between five oral frusemide preparations using renal chloride excretion and frusemide recovery.
    Eggers NJ; Kingsford M; Saint Joly CM; Jellett LB; Shirkey RJ
    N Z Med J; 1983 Nov; 96(744):963-6. PubMed ID: 6355931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of frusemide.
    Eggers NJ; Kingsford M; Saint Joly CM; Jellett LB; Maling TJ
    N Z Med J; 1980 May; 91(660):403-4. PubMed ID: 6931328
    [No Abstract]   [Full Text] [Related]  

  • 10. Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin?
    Akcicek F; Yalniz T; Basci A; Ok E; Mees EJ
    BMJ; 1995 Jan; 310(6973):162-3. PubMed ID: 7833755
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioavailability of two frusemide preparations.
    Beermann B; Dalén E; Lindström B
    Br J Clin Pharmacol; 1978 Dec; 6(6):537-8. PubMed ID: 728325
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous infusion of frusemide in refractory oedema [proceedings].
    Gray JM; Henry DA; Lawson DH; Tilstone WJ; Longman HJ
    Br J Pharmacol; 1978 Nov; 64(3):453P. PubMed ID: 719296
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced bioavailability and effect of furosemide given with food.
    Beermann B; Midskov C
    Eur J Clin Pharmacol; 1986; 29(6):725-7. PubMed ID: 3709617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic therapy in uremic patients.
    Dal Canton A; Russo D; Gallo R; Ardillo G; Trevico S; Cianciaruso B; Andreucci VE
    Kidney Int Suppl; 1985 Dec; 17():S154-6. PubMed ID: 3867786
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous infusion of frusemide in refractory oedema [proceedings].
    Gray JM; Henry DA; Lawson DH; Tilstone WJ
    Br J Clin Pharmacol; 1978 Nov; 6(5):461P. PubMed ID: 728311
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the diuretic response to oral and intravenous furosemide in "duretic-resistant" patients.
    Kelly MR; Blair AD; Forrey AW; Smidt NA; Cutler RE
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):1-9. PubMed ID: 401702
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined furosemide and human albumin treatment for diuretic-resistant edema.
    Elwell RJ; Spencer AP; Eisele G
    Ann Pharmacother; 2003 May; 37(5):695-700. PubMed ID: 12708949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal insensitivity to frusemide caused by chronic anticonvulsant therapy.
    Ahmad S
    Br Med J; 1974 Sep; 3(5932):657-9. PubMed ID: 4609534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evaluation of the effect of five disintegrants on the bioavailability of frusemide from 40mg tablets [proceedings].
    Rubinstein MH; Price EJ
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():5P. PubMed ID: 22681
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of lubricant type and concentration on the bioavailability of frusemide from 40mg tablets [proceedings].
    Rubinstein MH; Eastwood BA
    J Pharm Pharmacol; 1978 Dec; 30 Suppl():12P. PubMed ID: 32265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.